Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Accenture
Cantor Fitzgerald
Deloitte
Chinese Patent Office
Dow
Cipla
Medtronic
AstraZeneca

Generated: May 27, 2018

DrugPatentWatch Database Preview

GLUCOVANCE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Glucovance patents expire, and when can generic versions of Glucovance launch?

Glucovance is a drug marketed by Bristol Myers Squibb and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-nine patent family members in twenty-six countries.

The generic ingredient in GLUCOVANCE is glyburide; metformin hydrochloride. There are twenty drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the glyburide; metformin hydrochloride profile page.
Summary for GLUCOVANCE
International Patents:39
US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Bulk Api Vendors: 3
Clinical Trials: 7
Formulation / Manufacturing:see details
DailyMed Link:GLUCOVANCE at DailyMed
Drug patent expirations by year for GLUCOVANCE
Pharmacology for GLUCOVANCE
Synonyms for GLUCOVANCE
338752-31-1
5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide; 3-(diaminomethylidene)-1,1-dimethylguanidine; hydrochloride
AC1L43NM
Benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-, mixt. with N,N-dimethylimidodicarbonimidic diamide monohydrochloride
C23H28ClN3O5S.C4H11N5.Cl
DTXSID00187507
Glyburide and metformin hydrochloride
Glyburide mixture with metformin
Glyburide mixture with Metformin HCl
Glyburide mixture with Metformin hydrochloride
Glyburide-metformin
Glyburide-metformin hydrochloride mixt.
Glyburide-metformin hydrochloride mixture
GLYBURIDE; METFORMIN HYDROCHLORIDE
LS-178556
SCHEMBL7187343

US Patents and Regulatory Information for GLUCOVANCE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb GLUCOVANCE glyburide; metformin hydrochloride TABLET;ORAL 021178-001 Jul 31, 2000 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Bristol Myers Squibb GLUCOVANCE glyburide; metformin hydrochloride TABLET;ORAL 021178-002 Jul 31, 2000 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Bristol Myers Squibb GLUCOVANCE glyburide; metformin hydrochloride TABLET;ORAL 021178-003 Jul 31, 2000 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Non-Orange Book US Patents for GLUCOVANCE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
RE38629 Solid oral dosage form comprising a combination of metformin and glibenclamide ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Dow
Chubb
Daiichi Sankyo
QuintilesIMS
Accenture
Cipla
McKesson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.